Trial Profile
Safety and efficacy of mirabegron for the treatment of overactive bladder symptoms in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Oct 2019
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- 27 Sep 2018 New trial record
- 31 Aug 2018 Results presented at the 48th Annual Meeting of the International Continence Society